BR112014008196B8 - processo para a preparação de um composto da fórmula (i) - Google Patents
processo para a preparação de um composto da fórmula (i)Info
- Publication number
- BR112014008196B8 BR112014008196B8 BR112014008196A BR112014008196A BR112014008196B8 BR 112014008196 B8 BR112014008196 B8 BR 112014008196B8 BR 112014008196 A BR112014008196 A BR 112014008196A BR 112014008196 A BR112014008196 A BR 112014008196A BR 112014008196 B8 BR112014008196 B8 BR 112014008196B8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formula
- group
- 4alkyl
- 6alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 4
- 125000001153 fluoro group Chemical group F* 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 229910000487 osmium oxide Inorganic materials 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- JIWAALDUIFCBLV-UHFFFAOYSA-N oxoosmium Chemical compound [Os]=O JIWAALDUIFCBLV-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 abstract 1
- 229940071536 silver acetate Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
processo para a preparação de um composto da fórmula (i) a presente invenção refere-se a um processo de preparação de um composto da fórmula (i), hidratos ou solvatos destes; sendo que dito processo compreende as etapas de a) reação de um composto da fórmula (ii), com um agente de acilação ou um agente de sililação para produzir um composto da fórmula (iii); sendo que p1 é um grupo protetor selecionado de r1co-, ou r2si(r3)(r4)-, p2 é um grupo protetor selecionado de (r6r5r7)c-co-, ou (r2)si(r3)(r4)-, sendo que r1 é um grupo selecionado de c1-6alquila ou c3- 6cicloalquila, sendo cada grupo opcionalmente substituído por um ou mais substituintes independentemente selecionados de fluoro ou c1-4alquila; r2, r3 e r4 são cada um independentemente um grupo selecionado de c1-6alquila ou fenila, sendo cada grupo opcionalmente substituído por um ou mais substituintes independentemente selecionados de fluoro ou c1-4alquila; r5 é um grupo selecionado de c1-6alquila ou fenila, sendo cada grupo opcionalmente substituído por um ou mais substituintes independentemente selecionados de fluoro ou c1-4alquila; r6 e r7 são cada um independentemente hidrogênio ou um grupo selecionado de c1-6alquila ou fenila, sendo cada grupo opcionalmente substituído por um ou mais substituintes independentemente selecionados de fluoro ou c1-4alquila; b) reação do composto da fórmula (iii) na presença de pelo menos um agente oxidante selecionado de sal de permanganato, óxido de ósmio, peróxido de hidrogênio, ou iodo e acetato de prata para produzir composto da fórmula (iv); e c) desproteção do composto da fórmula (iv) para produzir composto da fórmula (i).
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161544591P | 2011-10-07 | 2011-10-07 | |
| US61/544,591 | 2011-10-07 | ||
| EP11184278 | 2011-10-07 | ||
| EP11184278.7 | 2011-10-07 | ||
| PCT/EP2012/069761 WO2013050553A1 (en) | 2011-10-07 | 2012-10-05 | Process for the production of estetrol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014008196A2 BR112014008196A2 (pt) | 2017-04-18 |
| BR112014008196B1 BR112014008196B1 (pt) | 2020-10-20 |
| BR112014008196B8 true BR112014008196B8 (pt) | 2020-12-15 |
Family
ID=48043195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014008196A BR112014008196B8 (pt) | 2011-10-07 | 2012-10-05 | processo para a preparação de um composto da fórmula (i) |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8987484B2 (pt) |
| EP (1) | EP2764008B1 (pt) |
| JP (1) | JP6196625B2 (pt) |
| KR (1) | KR102007874B1 (pt) |
| CN (1) | CN103890001B (pt) |
| AU (1) | AU2012320423C1 (pt) |
| BR (1) | BR112014008196B8 (pt) |
| CA (1) | CA2847813C (pt) |
| CL (1) | CL2014000802A1 (pt) |
| CY (1) | CY1118674T1 (pt) |
| DK (1) | DK2764008T3 (pt) |
| EA (1) | EA024003B1 (pt) |
| ES (1) | ES2593316T3 (pt) |
| HK (1) | HK1199882A1 (pt) |
| HR (1) | HRP20161282T1 (pt) |
| HU (1) | HUE028963T2 (pt) |
| IN (1) | IN2014MN00841A (pt) |
| LT (1) | LT2764008T (pt) |
| ME (1) | ME02527B (pt) |
| MX (1) | MX348917B (pt) |
| PL (1) | PL2764008T3 (pt) |
| PT (1) | PT2764008T (pt) |
| RS (1) | RS55231B1 (pt) |
| SG (1) | SG11201401282PA (pt) |
| SI (1) | SI2764008T1 (pt) |
| SM (1) | SMT201600375B (pt) |
| WO (1) | WO2013050553A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2835979C (en) | 2011-06-01 | 2018-05-01 | Estetra S.A. | Process for the production of estetrol intermediates |
| PT2714710T (pt) | 2011-06-01 | 2016-07-12 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| WO2013034780A2 (en) * | 2012-12-20 | 2013-03-14 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol and related compounds |
| JP6254289B2 (ja) * | 2013-09-18 | 2017-12-27 | クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． | エステトロールの製造プロセス |
| EP3310346B1 (en) | 2015-06-18 | 2021-03-24 | Estetra SPRL | Orodispersible tablet containing estetrol |
| KR102664563B1 (ko) | 2015-06-18 | 2024-05-09 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 에스테트롤 성분을 함유하는 구강분해성 투여 단위 |
| SI3310333T1 (sl) | 2015-06-18 | 2020-08-31 | Estetra Sprl | Orodisperzibilna enota odmerka, ki vsebuje komponento estetrola |
| CA2988485A1 (en) | 2015-06-18 | 2016-12-22 | Mithra Pharmaceuticals S.A. | Orodispersible tablet containing estetrol |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| EP3647413A1 (en) * | 2018-10-31 | 2020-05-06 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) | Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation |
| HU231240B1 (hu) * | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
| IT201900021879A1 (it) | 2019-11-22 | 2021-05-22 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROLO (ESTETROLO) ED INTERMEDI DI DETTO PROCESSO |
| JP2022549585A (ja) | 2019-09-27 | 2022-11-28 | インダストリアレ チミカ ソシエタ ア レスポンサビリタ リミタータ | （１５α，１６α，１７β）－エストラ－１，３，５（１０）－トリエン－３，１５，１６，１７－テトロール（エステトロール）および当該製法の中間体を調製するためのプロセス |
| IT201900017414A1 (it) | 2019-09-27 | 2021-03-27 | Ind Chimica Srl | Processo per la preparazione di (15α,16α,17β)-estra-1,3,5(10)-triene-3,15,16,17-tetrolo (Estetrolo) ed intermedi di detto processo |
| IT202100019631A1 (it) | 2021-07-23 | 2023-01-23 | Newchem S P A | Metodo per produrre estetrolo e i suoi intermedi |
| WO2023021026A1 (en) * | 2021-08-17 | 2023-02-23 | Aspen Oss B.V. | A synthetic pathway to estra-1,3,5(10)-triene-3,15a,16a,17b-tetrol |
| ES2976651A2 (es) | 2021-10-01 | 2024-08-06 | Ind Chimica Srl | PROCESO PARA PREPARAR (15alfa,16alfa,17beta)-ESTRA-1,3,5(10)-TRIENO-3,15,16,17-TETROL (ESTETROL) Y ESTETROL MONOHIDRATO |
| WO2024160373A1 (en) | 2023-02-02 | 2024-08-08 | Industriale Chimica S.R.L. | PROCESS FOR PREPARING (15α,16α,17β)-ESTRA-1,3,5(10)-TRIENE-3,15,16,17-TETROL (ESTETROL) MONOHYDRATE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| DE60025958T2 (de) * | 1999-12-02 | 2006-07-27 | Akzo Nobel N.V. | 14,15-beta-methylen substituierte androgene |
| PT1562976E (pt) | 2002-11-08 | 2010-08-12 | Pantarhei Bioscience Bv | Síntese do estetrol via esteróides derivados da estrona |
| UA89964C2 (ru) * | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| CA2835979C (en) | 2011-06-01 | 2018-05-01 | Estetra S.A. | Process for the production of estetrol intermediates |
| PT2714710T (pt) | 2011-06-01 | 2016-07-12 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
| EP2383279A1 (en) * | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
-
2012
- 2012-10-05 BR BR112014008196A patent/BR112014008196B8/pt active IP Right Grant
- 2012-10-05 ME MEP-2016-229A patent/ME02527B/me unknown
- 2012-10-05 SI SI201230705A patent/SI2764008T1/sl unknown
- 2012-10-05 RS RS20160859A patent/RS55231B1/sr unknown
- 2012-10-05 DK DK12778664.8T patent/DK2764008T3/en active
- 2012-10-05 US US14/349,940 patent/US8987484B2/en active Active
- 2012-10-05 EP EP12778664.8A patent/EP2764008B1/en active Active
- 2012-10-05 MX MX2014003723A patent/MX348917B/es active IP Right Grant
- 2012-10-05 WO PCT/EP2012/069761 patent/WO2013050553A1/en active Application Filing
- 2012-10-05 CA CA2847813A patent/CA2847813C/en active Active
- 2012-10-05 SG SG11201401282PA patent/SG11201401282PA/en unknown
- 2012-10-05 ES ES12778664.8T patent/ES2593316T3/es active Active
- 2012-10-05 PL PL12778664T patent/PL2764008T3/pl unknown
- 2012-10-05 PT PT127786648T patent/PT2764008T/pt unknown
- 2012-10-05 LT LTEP12778664.8T patent/LT2764008T/lt unknown
- 2012-10-05 CN CN201280049319.2A patent/CN103890001B/zh active Active
- 2012-10-05 JP JP2014533925A patent/JP6196625B2/ja active Active
- 2012-10-05 EA EA201490713A patent/EA024003B1/ru unknown
- 2012-10-05 AU AU2012320423A patent/AU2012320423C1/en active Active
- 2012-10-05 KR KR1020147007408A patent/KR102007874B1/ko active IP Right Grant
- 2012-10-05 HU HUE12778664A patent/HUE028963T2/en unknown
-
2014
- 2014-04-02 CL CL2014000802A patent/CL2014000802A1/es unknown
- 2014-05-05 IN IN841MUN2014 patent/IN2014MN00841A/en unknown
-
2015
- 2015-01-13 HK HK15100344.6A patent/HK1199882A1/zh unknown
-
2016
- 2016-10-05 HR HRP20161282TT patent/HRP20161282T1/hr unknown
- 2016-10-10 CY CY20161101001T patent/CY1118674T1/el unknown
- 2016-10-17 SM SM201600375T patent/SMT201600375B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014008196B8 (pt) | processo para a preparação de um composto da fórmula (i) | |
| ECSP099330A (es) | Compuesto de indol | |
| BR112016002083A2 (pt) | composto tetrazolinona e uso para o mesmo | |
| AR081385A1 (es) | Composiciones metodo y uso | |
| BR112015026644A2 (pt) | composto de tetrazolinona e uso do mesmo | |
| BR112015015031A2 (pt) | processo de glicoconjugação | |
| BRPI0813284A8 (pt) | Processo para a preparação de um composto da fórmula (i) e composto | |
| BR112014000665B8 (pt) | composto, composição farmacêutica, agente antimicrobiano, e, uso de um composto | |
| BR122018001898B8 (pt) | Composição para controlar pragas invertebradas e composição | |
| BR112012022634A2 (pt) | síntese de derivados de alto-tocoferolquinona e métodos de utilização dos mesmos | |
| MY153910A (en) | BICYCLIC y-AMINO ACID DERIVATIVE | |
| BR112015001839A2 (pt) | ibrutinibe deuterado | |
| BR112018005284A2 (pt) | ácido nucleico interligado guna, método para produzir o mesmo, e composto intermediário | |
| BR112016001979A2 (pt) | composto de tetrazolinona e uso do mesmo | |
| BR112013024223A2 (pt) | composto de poliéter, agente de cura usando o composto de poliéter, e método de produção do composto de poliéter | |
| CO2018010787A2 (es) | Compuesto de griseofulvina | |
| BR112014011930A2 (pt) | método para a produção de alcano diol | |
| UY32131A (es) | Compuestos de anillo fusionado y uso de los mismos | |
| MY171201A (en) | New carbamate glycolipid and use thereof | |
| BR112015011897A2 (pt) | novos moduladores seletivos do receptor de andrógeno | |
| MX2014008247A (es) | Calmangafodipir, una nueva entidad quimica, y otros complejos de metal mezclados, metodos de preparacion, composiciones y metodos de tratamiento. | |
| BR112014024437B8 (pt) | método para produzir bis (beta-epoxipropil)- sulfeto e bis (beta-epoxipropil) polissulfeto | |
| BR112016011778A8 (pt) | pirazol fluorofenila, seus usos, e composição farmacêutica | |
| BR112015001431B8 (pt) | Processos de preparação de um composto sulfonimida aquoso e processos de preparação de (rf¹- so2)(rf²-so2)nm^b | |
| TR201901381T4 (tr) | Ulipristal asetat ve 4'-asetil analoğunun sentezi için endüstriyel süreç. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: ESTETRA S.P.R.L. (BE) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2598 DE 20/10/2020 QUANTO AO TITULO E O ENDERECO. |
|
| B25A | Requested transfer of rights approved |
Owner name: MITHRA RECHERCHE ET DEVELOPPEMENT SA (BE) |